Healthcare News and Research

Latest Healthcare News and Research

Selling of Obamacare begins in earnest

President Barack Obama tells the New York Times that his plan to build support for the health law is simply to implement it. Meanwhile, high level aides and supporters meet to craft a new message, while volunteers for the nonprofit Enroll America fan out across the country to tell the uninsured about new coverage options.

30 Jul 2013

State highlights: Mass. insurers back out of disabled adults experiment

Massachusetts health insurers' reluctance to join a national experiment to improve care for disabled lower-income adults has forced the state to scale back the program even before it starts. Massachusetts is among the first states to roll out the national program, but half the insurers that were expected to participate backed out because they feared losing money. That will mean fewer options for patients when enrollment opens for the voluntary "One Care" program in October (Conaboy, 7/29).

30 Jul 2013

Maryland regulators approve premium rates much lower than insurers sought

The Maryland insurance commissioner Therese M. Goldsmith approved premium increases Friday for nine insurance companies who applied to sell plans to individuals through a state exchange, which was established by the health law.

30 Jul 2013

Houston Methodist, Istanbul University Hospitals to collaborate on educational projects

Houston Methodist Global Health Care Services, the global subsidiary of Houston Methodist Hospital in Texas, USA, and Istanbul University Hospitals - General Directorate in Istanbul, Turkey, have signed a collaboration agreement in the areas of education and training.

30 Jul 2013

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

The USPSTF agreed with the CDC that since most patients (75%) who are currently infected with hepatitis C were born between 1945 - 1965, and since risk-based screening has not been successful in identifying these individuals, that a one time age-based hepatitis C blood test was necessary.

29 Jul 2013

First Edition: July 29, 2013

Today's headlines include reports about the White House's strategy for building support for the health law.

29 Jul 2013

Saudi and UK scientists provide detailed picture of MERS coronavirus

Saudi and UK scientists provide the most detailed picture yet of the clinical and laboratory characteristics of Middle East Respiratory Syndrome (MERS) coronavirus, revealing a wide range of clinical symptoms and an extremely high death rate among patients with co-existing medical conditions.

29 Jul 2013

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.

29 Jul 2013

Technique for developing more targeted drugs using molecular "robots"

Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more specific populations of cells.

29 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

First Edition: July 26, 2013

Today's headlines include reports about an effort by some GOP lawmakers to force a showdown over health law funding.

26 Jul 2013

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Gout is a relatively common arthritic disease that affects about 4% (I in 25) of the population. It results from the deposition of uric acid in joints due to elevated blood levels and a resulting inflammation ensues which is very painful.

26 Jul 2013

Columbia Laboratories’ Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

26 Jul 2013

Piramal's Healthcare invests USD 2.5 million to upgrade ADC manufacturing suites

Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand.

26 Jul 2013

Compliance leaders give insight and thoughts in new ebook

Regulatory non compliance costs the pharma industry billions in fines, audits and much more each year. To avoid these fines and bad reputation pharma companies rely heavily on their compliance teams, who provide oversight from R&D to the very end of a product cycle.

26 Jul 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

GAO analysis: Health premiums vary widely

The Government Accountability Office report, which is based on prices reported by insurers, shows that consumers face a wide range of premium prices, deductibles and annual exposure to out-of-pocket costs.

26 Jul 2013

Journal of Racial and Ethnic Health Disparities to address crucial healthcare problem in US

Springer has entered into an agreement with the W. Montague Cobb/National Medical Association (NMA) Health Institute to publish the Journal of Racial and Ethnic Health Disparities. Starting in 2014 the new society journal will be published quarterly, electronically on link.springer.com and in print.

26 Jul 2013

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

In a unique partnership, Zydus, India's fourth largest healthcare group and an innovation-led global healthcare provider, and IDRI, a Seattle-based non-profit research and product development organization, announced today they are collaborating on the production and clinical development of IDRI's visceral leishmaniasis vaccine candidate, designed to prevent the deadly parasitic disease.

26 Jul 2013

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

Both the frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries, and facilities with more frequent and longer contact had fewer patient deaths and hospitalizations, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

26 Jul 2013

Healthcare News and Research

Latest Healthcare News and Research

Selling of Obamacare begins in earnest

State highlights: Mass. insurers back out of disabled adults experiment

Maryland regulators approve premium rates much lower than insurers sought

Houston Methodist, Istanbul University Hospitals to collaborate on educational projects

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

First Edition: July 29, 2013

Saudi and UK scientists provide detailed picture of MERS coronavirus

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

Technique for developing more targeted drugs using molecular "robots"

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

First Edition: July 26, 2013

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Columbia Laboratories’ Board of Directors set a ratio of 1-for-8 for its reverse stock split

Piramal's Healthcare invests USD 2.5 million to upgrade ADC manufacturing suites

Compliance leaders give insight and thoughts in new ebook

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

GAO analysis: Health premiums vary widely

Journal of Racial and Ethnic Health Disparities to address crucial healthcare problem in US

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in